James Coyle Sells 88,444 Shares for $2.55M

James Coyle reported a sale of 88,444 shares of Common Stock on 02/20/2026 for $2,549,822.84 via a Form 144 filing.

Rhea-AI Filing Summary

James Coyle reported a sale of 88,444 shares of Common Stock on 02/20/2026 for $2,549,822.84 via a Form 144 filing. The record also lists prior issuer-sided grants and employee stock purchase plan (ESPP) purchases, including a 12,700 share restricted stock vesting on 05/09/2023.

The filing lists multiple ESPP purchase entries by month and small periodic share purchases by the issuer, indicating compensation and employee-purchase activity in prior periods. Transaction counterparties and cash-flow treatment beyond the reported sale amount are not detailed in the excerpt.

Key Figures

Shares sold: 88,444 shares Aggregate proceeds: $2,549,822.84 Restricted stock vesting: 12,700 shares +1 more

4 metrics

Shares sold 88,444 shares Sale by James Coyle on 02/20/2026

Aggregate proceeds $2,549,822.84 Proceeds reported for the 02/20/2026 sale

Restricted stock vesting 12,700 shares Restricted Stock Vesting on 05/09/2023

ESPP periodic purchases multiple small lots (e.g., 93–296 shares) Monthly ESPP Purchase entries from 10/31/2022 through 02/29/2024

Key Terms

Form 144, ESPP Purchase, Restricted Stock Vesting

3 terms

Form 144 regulatory

"Securities Sold During The Past 3 Months — James Coyle 02/20/2026 88444"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

ESPP Purchase financial

"Common | 10/31/2022 | ESPP Purchase | Issuer"

Restricted Stock Vesting financial

"Common | 05/09/2023 | Restricted Stock Vesting | Issuer | 12700"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did the Form 144 for OPLN disclose about James Coyle's transaction?

It discloses a sale of 88,444 shares for $2,549,822.84 on 02/20/2026. The form lists the transaction size and aggregate proceeds and includes earlier issuer-side share activity such as ESPP purchases and a 12,700-share restricted stock vesting on 05/09/2023.

How many shares vested for restricted stock in the filing and when?

12,700 restricted shares vested on 05/09/2023. That vesting is recorded under "Restricted Stock Vesting" and is shown alongside multiple ESPP purchase entries spanning 2022–2024 in the provided excerpt.

What proceeds were reported from the securities sold during the past three months?

The filing reports aggregate proceeds of $2,549,822.84. This amount corresponds to the sale of 88,444 Common shares by James Coyle on 02/20/2026 as shown in the excerpt.

Does the excerpt show ongoing ESPP purchases and their timing?

Yes. Multiple ESPP Purchase entries are listed with monthly dates from 10/31/2022 through 02/29/2024. Each line shows small periodic share purchases (for example, entries of 93, 99, 104 shares) recorded as issuer-side ESPP purchases in the excerpt.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/06/2026 - 12:50 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001891323
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	OPENLANE, Inc.
SEC File Number	001-34568
Address of Issuer	11299 N. ILLINOIS STREET CARMEL INDIANA 46032
Phone	(800) 923-3725
Name of Person for Whose Account the Securities are To Be Sold	Coyle James P
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	15000	547650.00	105946106	05/06/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	10/31/2022	ESPP Purchase	Issuer			93	10/31/2022	Cash
Common	11/30/2022	ESPP Purchase	Issuer			99	11/30/2022	Cash
Common	12/30/2022	ESPP Purchase	Issuer			104	12/30/2022	Cash
Common	01/31/2023	ESPP Purchase	Issuer			93	01/31/2023	Cash
Common	02/28/2023	ESPP Purchase	Issuer			95	02/28/2023	Cash
Common	03/31/2023	ESPP Purchase	Issuer			151	03/31/2023	Cash
Common	04/28/2023	ESPP Purchase	Issuer			104	04/28/2023	Cash
Common	05/09/2023	Restricted Stock Vesting	Issuer			12700	05/09/2023	Compensation
Common	05/31/2023	ESPP Purchase	Issuer			94	05/31/2023	Cash
Common	06/30/2023	ESPP Purchase	Issuer			93	06/30/2023	Cash
Common	07/31/2023	ESPP Purchase	Issuer			90	07/31/2023	Cash
Common	08/31/2023	ESPP Purchase	Issuer			121	08/31/2023	Cash
Common	09/29/2023	ESPP Purchase	Issuer			296	09/29/2023	Cash
Common	10/31/2023	ESPP Purchase	Issuer			202	10/31/2023	Cash
Common	11/30/2023	ESPP Purchase	Issuer			186	11/30/2023	Cash
Common	12/29/2023	ESPP Purchase	Issuer			183	12/29/2023	Cash
Common	01/31/2024	ESPP Purchase	Issuer			193	01/31/2024	Cash
Common	02/29/2024	ESPP Purchase	Issuer			103	02/29/2024	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
James Coyle 11299 N. Illinois Street Suite 500 Carmel IN 46032	Common	02/20/2026	88444	2549822.84

144: Remarks and Signature

Remarks
Date of Notice	05/06/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/Wade Moss, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for James P. Coyle
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)